CRL logo

CRL CAPEX

CRL Annual CAPEX

$318.53 M
-$6.21 M-1.91%

30 December 2023

CRL CAPEX Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CRL Quarterly CAPEX

$38.72 M
-$765.00 K-1.94%

28 September 2024

CRL Quarterly CAPEX Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CRL TTM CAPEX

$235.67 M
-$27.23 M-10.36%

28 September 2024

CRL TTM CAPEX Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CRL CAPEX Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-1.9%-50.6%-26.0%
3 y3 years+91.2%-50.6%-26.0%
5 y5 years+127.4%-50.6%-26.0%

CRL CAPEX High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-1.9%+39.2%-63.8%at low-32.9%+3.0%
5 y5-year-1.9%+126.7%-63.8%+50.5%-32.9%+67.7%
alltimeall time-1.9%+2574.7%-63.8%+1498.7%-32.9%+8359.2%

Charles River Laboratories International CAPEX History

DateAnnualQuarterlyTTM
Sept 2024
-
$38.72 M(-1.9%)
$235.67 M(-10.4%)
June 2024
-
$39.49 M(-50.1%)
$262.90 M(-9.6%)
Mar 2024
-
$79.14 M(+1.0%)
$290.80 M(-8.7%)
Dec 2023
$318.53 M(-1.9%)
$78.32 M(+18.8%)
$318.53 M(-3.3%)
Sept 2023
-
$65.95 M(-2.1%)
$329.23 M(-1.9%)
June 2023
-
$67.38 M(-37.0%)
$335.68 M(-4.4%)
Mar 2023
-
$106.88 M(+20.1%)
$351.14 M(+8.1%)
Dec 2022
$324.73 M(+41.9%)
$89.02 M(+23.0%)
$324.73 M(-2.9%)
Sept 2022
-
$72.39 M(-12.6%)
$334.48 M(+5.3%)
June 2022
-
$82.85 M(+3.0%)
$317.63 M(+13.0%)
Mar 2022
-
$80.46 M(-18.5%)
$281.21 M(+22.9%)
Dec 2021
$228.77 M(+37.4%)
$98.78 M(+77.9%)
$228.77 M(+5.0%)
Sept 2021
-
$55.54 M(+19.6%)
$217.85 M(+15.6%)
June 2021
-
$46.43 M(+65.6%)
$188.50 M(+11.6%)
Mar 2021
-
$28.03 M(-68.1%)
$168.87 M(+1.4%)
Dec 2020
$166.56 M(+18.5%)
$87.85 M(+235.5%)
$166.56 M(+16.8%)
Sept 2020
-
$26.18 M(-2.3%)
$142.54 M(-5.9%)
June 2020
-
$26.80 M(+4.2%)
$151.52 M(+1.4%)
Mar 2020
-
$25.72 M(-59.7%)
$149.50 M(+6.4%)
Dec 2019
$140.51 M(+0.3%)
$63.84 M(+81.6%)
$140.51 M(-3.3%)
Sept 2019
-
$35.16 M(+41.9%)
$145.35 M(+9.6%)
June 2019
-
$24.78 M(+48.1%)
$132.63 M(+2.8%)
Mar 2019
-
$16.73 M(-75.6%)
$129.06 M(-7.9%)
Dec 2018
$140.05 M(+69.9%)
$68.68 M(+206.1%)
$140.05 M(+40.2%)
Sept 2018
-
$22.44 M(+5.8%)
$99.88 M(+0.4%)
June 2018
-
$21.21 M(-23.5%)
$99.45 M(+5.5%)
Mar 2018
-
$27.73 M(-2.7%)
$94.24 M(+14.3%)
Dec 2017
$82.43 M(+49.1%)
$28.50 M(+29.5%)
$82.43 M(+3.5%)
Sept 2017
-
$22.01 M(+37.6%)
$79.61 M(+18.5%)
June 2017
-
$16.00 M(+0.5%)
$67.16 M(+6.7%)
Mar 2017
-
$15.92 M(-38.0%)
$62.96 M(+13.9%)
Dec 2016
$55.29 M(-12.6%)
$25.68 M(+168.4%)
$55.29 M(-4.4%)
Sept 2016
-
$9.57 M(-18.9%)
$57.85 M(-1.5%)
June 2016
-
$11.79 M(+42.9%)
$58.74 M(-3.5%)
Mar 2016
-
$8.25 M(-70.8%)
$60.85 M(-3.8%)
Dec 2015
$63.25 M(+11.1%)
$28.24 M(+170.2%)
$63.25 M(+2.0%)
Sept 2015
-
$10.45 M(-24.8%)
$62.03 M(+1.7%)
June 2015
-
$13.91 M(+30.6%)
$60.98 M(+8.1%)
Mar 2015
-
$10.65 M(-60.6%)
$56.38 M(-1.0%)
Dec 2014
$56.92 M(+45.4%)
$27.02 M(+187.4%)
$56.92 M(+30.1%)
Sept 2014
-
$9.40 M(+0.9%)
$43.74 M(+0.7%)
June 2014
-
$9.31 M(-16.8%)
$43.44 M(-1.1%)
Mar 2014
-
$11.19 M(-19.1%)
$43.91 M(+12.2%)
Dec 2013
$39.15 M(-17.6%)
$13.84 M(+52.1%)
$39.15 M(+0.2%)
Sept 2013
-
$9.10 M(-7.1%)
$39.06 M(-2.9%)
June 2013
-
$9.79 M(+52.3%)
$40.20 M(+0.9%)
Mar 2013
-
$6.43 M(-53.2%)
$39.85 M(-16.2%)
Dec 2012
$47.53 M
$13.74 M(+34.1%)
$47.53 M(-22.4%)
Sept 2012
-
$10.24 M(+8.5%)
$61.27 M(+3.4%)
June 2012
-
$9.44 M(-33.1%)
$59.25 M(+4.9%)
DateAnnualQuarterlyTTM
Mar 2012
-
$14.11 M(-48.6%)
$56.47 M(+14.9%)
Dec 2011
$49.14 M(+14.7%)
$27.47 M(+234.1%)
$49.14 M(+30.4%)
Sept 2011
-
$8.22 M(+23.4%)
$37.68 M(-2.3%)
June 2011
-
$6.66 M(-1.9%)
$38.59 M(-4.4%)
Mar 2011
-
$6.79 M(-57.6%)
$40.36 M(-5.8%)
Dec 2010
$42.86 M(-46.3%)
$16.01 M(+75.4%)
$42.86 M(-0.7%)
Sept 2010
-
$9.13 M(+8.3%)
$43.18 M(-17.8%)
June 2010
-
$8.43 M(-9.3%)
$52.52 M(-18.6%)
Mar 2010
-
$9.29 M(-43.1%)
$64.52 M(-19.2%)
Dec 2009
$79.85 M(-59.5%)
$16.33 M(-11.6%)
$79.85 M(-26.3%)
Sept 2009
-
$18.46 M(-9.6%)
$108.38 M(-20.6%)
June 2009
-
$20.44 M(-17.0%)
$136.56 M(-24.6%)
Mar 2009
-
$24.63 M(-45.1%)
$181.08 M(-8.1%)
Dec 2008
$197.08 M(-13.2%)
$44.85 M(-3.8%)
$197.08 M(-18.4%)
Sept 2008
-
$46.64 M(-28.2%)
$241.59 M(-1.5%)
June 2008
-
$64.95 M(+59.9%)
$245.28 M(+6.8%)
Mar 2008
-
$40.63 M(-54.5%)
$229.74 M(+1.2%)
Dec 2007
$227.04 M(+24.9%)
$89.36 M(+77.5%)
$227.04 M(+3.4%)
Sept 2007
-
$50.34 M(+1.9%)
$219.66 M(+3.5%)
June 2007
-
$49.41 M(+30.3%)
$212.29 M(+17.8%)
Mar 2007
-
$37.92 M(-53.7%)
$180.28 M(-0.8%)
Dec 2006
$181.75 M(+92.3%)
$81.99 M(+90.8%)
$181.75 M(+46.2%)
Sept 2006
-
$42.97 M(+146.9%)
$124.33 M(-2.5%)
June 2006
-
$17.40 M(-55.8%)
$127.55 M(+5.0%)
Mar 2006
-
$39.39 M(+60.3%)
$121.51 M(+28.6%)
Dec 2005
$94.52 M(+111.3%)
$24.57 M(-46.8%)
$94.52 M(+2.1%)
Sept 2005
-
$46.19 M(+306.6%)
$92.58 M(+63.5%)
June 2005
-
$11.36 M(-8.4%)
$56.63 M(+7.6%)
Mar 2005
-
$12.40 M(-45.2%)
$52.61 M(+17.6%)
Dec 2004
$44.73 M(+36.8%)
$22.62 M(+120.9%)
$44.73 M(+27.6%)
Sept 2004
-
$10.24 M(+39.5%)
$35.05 M(+16.4%)
June 2004
-
$7.34 M(+62.3%)
$30.12 M(-5.9%)
Mar 2004
-
$4.53 M(-65.0%)
$31.99 M(-2.2%)
Dec 2003
$32.70 M(-12.9%)
$12.94 M(+143.4%)
$32.70 M(-8.4%)
Sept 2003
-
$5.32 M(-42.3%)
$35.70 M(-5.3%)
June 2003
-
$9.22 M(+76.1%)
$37.69 M(-1.4%)
Mar 2003
-
$5.24 M(-67.1%)
$38.24 M(+1.9%)
Dec 2002
$37.54 M(+2.4%)
$15.93 M(+118.0%)
$37.54 M(-0.5%)
Sept 2002
-
$7.31 M(-25.2%)
$37.74 M(-3.8%)
June 2002
-
$9.77 M(+115.5%)
$39.24 M(+6.2%)
Mar 2002
-
$4.54 M(-71.9%)
$36.94 M(+0.8%)
Dec 2001
$36.66 M(+135.5%)
$16.13 M(+83.2%)
$36.66 M(+33.0%)
Sept 2001
-
$8.80 M(+17.8%)
$27.57 M(+30.1%)
June 2001
-
$7.47 M(+75.7%)
$21.18 M(+24.4%)
Mar 2001
-
$4.25 M(-39.6%)
$17.03 M(+9.4%)
Dec 2000
$15.56 M(+20.2%)
$7.04 M(+190.5%)
$15.56 M(+82.5%)
Sept 2000
-
$2.42 M(-27.1%)
$8.53 M(+39.7%)
June 2000
-
$3.32 M(+19.2%)
$6.11 M(+119.2%)
Mar 2000
-
$2.79 M
$2.79 M
Dec 1999
$12.95 M(+8.7%)
-
-
Dec 1998
$11.91 M
-
-

FAQ

  • What is Charles River Laboratories International annual capital expenditures?
  • What is the all time high annual CAPEX for Charles River Laboratories International?
  • What is Charles River Laboratories International annual CAPEX year-on-year change?
  • What is Charles River Laboratories International quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for Charles River Laboratories International?
  • What is Charles River Laboratories International quarterly CAPEX year-on-year change?
  • What is Charles River Laboratories International TTM capital expenditures?
  • What is the all time high TTM CAPEX for Charles River Laboratories International?
  • What is Charles River Laboratories International TTM CAPEX year-on-year change?

What is Charles River Laboratories International annual capital expenditures?

The current annual CAPEX of CRL is $318.53 M

What is the all time high annual CAPEX for Charles River Laboratories International?

Charles River Laboratories International all-time high annual capital expenditures is $324.73 M

What is Charles River Laboratories International annual CAPEX year-on-year change?

Over the past year, CRL annual capital expenditures has changed by -$6.21 M (-1.91%)

What is Charles River Laboratories International quarterly capital expenditures?

The current quarterly CAPEX of CRL is $38.72 M

What is the all time high quarterly CAPEX for Charles River Laboratories International?

Charles River Laboratories International all-time high quarterly capital expenditures is $106.88 M

What is Charles River Laboratories International quarterly CAPEX year-on-year change?

Over the past year, CRL quarterly capital expenditures has changed by -$39.60 M (-50.56%)

What is Charles River Laboratories International TTM capital expenditures?

The current TTM CAPEX of CRL is $235.67 M

What is the all time high TTM CAPEX for Charles River Laboratories International?

Charles River Laboratories International all-time high TTM capital expenditures is $351.14 M

What is Charles River Laboratories International TTM CAPEX year-on-year change?

Over the past year, CRL TTM capital expenditures has changed by -$82.85 M (-26.01%)